USFDA nod to Alembic Pharma breast cancer injection Fulvestrant Ruchika Sharma26 Dec 2022 1:15 PM ISTFulvestrant Injection is an estrogen receptor antagonist indicated for the treatment of breast cancer.
Alembic Pharma gets PAS approval from USFDA for Pregabalin Capsules Ruchika Sharma22 Dec 2022 3:32 PM ISTPregabalin Capsules are indicated for neuropathic pain, postherpetic neuralgia, and other indications.
USFDA inspection: Alembic Pharma gets Form 483 with 5 observations Ruchika Sharma19 Dec 2022 2:55 PM ISTVadodara: Drugmaker, Alembic Pharma, has recently announced that the company has received a Form 483 with 5 procedural observations from US Food...
Alembic Pharma gets USFDA EIR for Oncology Injectable Formulation Facility at Panelav Ruchika Sharma10 Dec 2022 11:18 AM ISTVadodara: Drugmaker Alembic Pharma has recently announced that the Company has received Establishment Inspection Report (EIR) from US Food and Drug...
USFDA nod to Alembic Pharma Desonide Cream Ruchika Sharma9 Dec 2022 1:11 PM ISTDesonide Cream, 0.05% is a Low potency corticosteroid indicated for the relief of inflammatory and Pruritic manifestations of...
Alembic Pharma osteoarthritis drug gets USFDA okay Ruchika Sharma1 Dec 2022 5:45 PM ISTDiclofenac Sodium Topical Solution is indicated for the treatment of the pain of osteoarthritis of the knee(s).
Alembic Pharma bags USFDA nod for Hypertension drug Nifedipine Extended Release Ruchika Sharma21 Nov 2022 2:30 PM ISTNifedipine Extended-Release Tablets are indicated for the management of i) Vasospastic Angina ii) Chronic Stable Angina (Classical EffortAssociated...
Alembic Pharma bags USFDA nod for alkylating drug Cyclophosphamide Ruchika Sharma14 Nov 2022 11:33 AM ISTVadodara: Drugmaker Alembic Pharmaceuticals Limited today announced that the company has received final approval from the US Food & Drug...
Alembic Pharma bags USFDA approval for Pain relief injection Ketorolac Tromethamine Ruchika Sharma3 Nov 2022 12:30 PM ISTKetorolac Tromethamine is indicated for the short-term (≤5 days) management of moderately severe acute pain in adult patients.
Alembic Pharma secures USFDA okay for Mesalamine ER Capsules Ruchika Sharma2 Nov 2022 11:18 AM ISTMesalamine Extended-Release Capsules are indicated for the maintenance of remission of ulcerative colitis in adults.
Alembic Pharma bags USFDA approval for Glycopyrrolate Injection Ruchika Sharma1 Nov 2022 12:33 PM ISTGlycopyrrolate Injection is indicated for use as a preoperative antimuscarinic to reduce salivary, tracheobronchial, and pharyngeal secretions; to...
Alembic Pharma Vadodara facility concludes USFDA inspection with zero observations Ruchika Sharma27 Oct 2022 1:30 PM ISTVadodara: Alembic Pharma has recently announced that the Company has successfully completed the United States Food and Drug Administration...
